Bard Associates’s Viatris VTRS Stock Holding History

Bard Associates’s Portfolio VTRS Stock Details VTRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$683	Hold	43	–	–	﹤0.01%	288
2026 Q1	$581	Buy	+43	New	+$602	﹤0.01%	284

Other funds holding VTRS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

DSA

Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Bard Associates's VTRS Position: Q2 2026 in Review

Bard Associates held its Viatris (VTRS) position steady in Q2 2026 at 43 shares worth $683. The position accounts for ﹤0.01% of the portfolio, ranked #288.

Bard Associates first reported a position in VTRS in Q1 2026 and has held it in 2 quarters since. 1,026 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

Bard Associates held 43 shares of Viatris worth $683 as of Q2 2026.
Bard Associates left its Viatris share count unchanged in Q2 2026.
Viatris made up ﹤0.01% of Bard Associates's portfolio in Q2 2026, its #288 holding.
Bard Associates first reported a position in Viatris in Q1 2026 and has held it in 2 quarters since.
1,026 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on Bard Associates's 13F filing for Q2 2026, filed 12 Aug 2026.